Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

PURPOSE OF REVIEW: This review offers a critical narrative evaluation of emerging evidence that sodium-glucose co-transporter-2 (SGLT2) inhibitors exert nephroprotective effects in people with type 2 diabetes. RECENT FINDINGS: The SGLT2 inhibitor class of glucose-lowering agents has recently shown b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Clifford J., Day, Caroline, Bellary, Srikanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Microvascular Complications—Nephropathy (B Roshanravan, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888485/
https://www.ncbi.nlm.nih.gov/pubmed/35113333
http://dx.doi.org/10.1007/s11892-021-01442-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888485/
https://www.ncbi.nlm.nih.gov/pubmed/35113333
http://dx.doi.org/10.1007/s11892-021-01442-z

Ejemplares similares